{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:52:28Z","timestamp":1790887948081,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/rhu.0b013e3181e931fa","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T03:31:14Z","timestamp":1277263874000},"page":"237-239","source":"Crossref","is-referenced-by-count":26,"title":["Stiff-Person Syndrome"],"prefix":"10.1097","volume":"16","author":[{"given":"Eugene A.","family":"Bacorro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210207","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-2008-1041222","article-title":"Stiff-Man Syndrome.","volume":"11","author":"McEvoy","year":"1991","journal-title":"Semin Neuro"},{"key":"R2-9-20210207","first-page":"106","article-title":"Stiff-person syndrome.","volume":"7","author":"Lockman","year":"2007","journal-title":"Pract Neurol"},{"key":"R3-9-20210207","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mus.20653","article-title":"Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome.","volume":"34","author":"Espay","year":"2006","journal-title":"Muscle Nerve"},{"key":"R4-9-20210207","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00415-008-0007-7","article-title":"Levetiracetam in stiff-person syndrome.","volume":"255","author":"Sechi","year":"2008","journal-title":"J Neurol"},{"key":"R5-9-20210207","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.41.10.1588","article-title":"Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome.","volume":"41","author":"Brashear","year":"1991","journal-title":"Neurology"},{"key":"R6-9-20210207","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for stiff-person syndrome.","volume":"345","author":"Dalakas","year":"2001","journal-title":"N Engl J Med"},{"key":"R7-9-20210207","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/jnnp.2004.051144","article-title":"Treatment of stiff-person syndrome with rituximab.","volume":"76","author":"Baker","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-9-20210207","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1055\/s-2007-979064","article-title":"Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study.","volume":"29","author":"Wilt","year":"1997","journal-title":"Horm Metab Res"},{"key":"R9-9-20210207","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.nrl.0000126587.37087.1a","article-title":"Stiff-person syndrome.","volume":"10","author":"Murinson","year":"2004","journal-title":"Neurologist"},{"key":"R10-9-20210207","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archneur.62.6.970","article-title":"Brain \u03b3-aminobutyric acid changes in stiff-person syndrome.","volume":"62","author":"Levy","year":"2005","journal-title":"Arch Neurol"},{"key":"R11-9-20210207","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","article-title":"Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease.","volume":"71","author":"Murinson","year":"2008","journal-title":"Neurology"},{"key":"R12-9-20210207","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00646.x","article-title":"B-lymphocyte contributions to human autoimmune disease.","volume":"223","author":"Yanaba","year":"2008","journal-title":"Immunol Rev"},{"key":"R13-9-20210207","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action.","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am J Transplant"},{"key":"R14-9-20210207","doi-asserted-by":"crossref","first-page":"20878","DOI":"10.1073\/pnas.0709205105","article-title":"Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice.","volume":"104","author":"Bouaziz","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-9-20210207","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar1954","article-title":"Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.","volume":"8","author":"Vigna-Perez","year":"2006","journal-title":"Arthritis Res Ther"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124743-201008000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:31:05Z","timestamp":1786041065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124743-201008000-00009"}},"subtitle":["Persistent Elevation of Glutamic Acid Decarboxylase Antibodies Despite Successful Treatment With Rituximab"],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3181e931fa","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}